Form D · Biotechnology

Flexion Therapeutics Inc

Woburn, MA · CIK 0001419600

Offering snapshot reported Dec 14, 2012 · SEC filing

Reported sold
$20M
Offering amount: $20M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 3, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 14, 2012Initial$19,999,999No comparison7SEC filing
Oct 15, 2009Initial$20,036,200No comparison19SEC filing
Jul 16, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 16, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 7, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Nov 21, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-188417

Source: Form D, filed Dec 14, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Neil Bodick Executive
Bradley Bolzon Director
Michael Clayman Director, Executive
Samuel Colella Director
Arthur Fratamico Executive
Elaine Jones Director
Heath Lukatch Director
Patrick Mahaffy Director
Alan Milinazzo Director
Andrew Schwab Director
Rafaele Tordjman Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
300 World Trade Center Suite 2460
Woburn, MA, 01801